Skip to main content
. 2022 Jul 8;13:876235. doi: 10.3389/fphar.2022.876235

FIGURE 2.

FIGURE 2

Storax inhibits Albumin-Alexa594 leakage from BBB to brain parenchyma at 6 h after stroke. (A) Representative images of EB staining. (B) Quantification of Evans blue (EB) leakage. (C) Representative images of Albumin-Alexa594 and Glut-1staining. (D,E) Quantification of fluorescent Albumin-Alexa594 and Glut-1 intensity in the parenchyma of the brain. Data were shown as the mean ± SEM. # p < 0.05 vs. Control group, *p < 0.05 vs. Storax group, bar = 20 μm and bar = 100 μm, n = 7 for EB leakage assay and n = 3 for Albumin-Alexa594 leakage assay.